Sheaff Brock Investment Advisors, LLC Abb Vie Inc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.13 Billion
- Q3 2024
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 61,029 shares of ABBV stock, worth $10.1 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
61,029
Previous 62,570
2.46%
Holding current value
$10.1 Million
Previous $10.7 Million
12.3%
% of portfolio
1.07%
Previous 1.0%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
3,843Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$28.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$22.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.1 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.67 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.44 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $294B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...